Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Polycystic Ovary Syndrome × Profasi × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 1 Ovarian Hyperstimulation Syndrome 1

Interventions

Triptorelin Pamoate 4 Diet, Mediterranean 2 Chorionic Gonadotropin 2 ganirelix 1 cinnulin PF 1 cetrorelix 1 Thioctic Acid 1 Surveys and Questionnaires 1 Profasi 1 Positron-Emission Tomography 1 Pentoxifylline 1 Menotropins 1 LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1 Gonadotropins 1 Clomiphene 1 Cabergoline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01815138 2018-10-26

Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS

UConn Health

Phase 4 Completed

89 enrolled 13 charts

Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡